智通财经APP获悉，今海医疗科技(02225)早盘涨超18%。截至发稿，涨15.60%，报4.855港元，成交额5786.83万港元。
消息面上，9月7日，深交所公告，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自9月7日起生效。其中，今海医疗科技获纳入港股通名单。此次纳入有助拓宽股东基础、吸引长期机构投资者，并提升股份交易流动性。
值得注意的是，上半年，今海医疗科技收入结构显著优化，战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。来自微创手术解决方案、医疗产品及相关服务费的收入占比已攀升至74.73%，成为当之无愧的新收入支柱。继2025年医疗器械销售收益实现良好增长后，2026年上半年该业务收益同比激增301.5%，达到2542.7万新加坡元，可持续增长动力充足。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.